278 related articles for article (PubMed ID: 32097663)
21. Walking a Tightrope: A Perspective of Resveratrol Effects on Breast Cancer.
Bartolacci C; Andreani C; Amici A; Marchini C
Curr Protein Pept Sci; 2018; 19(3):311-322. PubMed ID: 28079008
[TBL] [Abstract][Full Text] [Related]
22. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
23. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
24. Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression.
Guo L; Zheng P; Fan H; Wang H; Xu W; Zhou W
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935760
[TBL] [Abstract][Full Text] [Related]
25. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
[TBL] [Abstract][Full Text] [Related]
26. The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4.
Su M; Huang J; Liu S; Xiao Y; Qin X; Liu J; Pi C; Luo T; Li J; Chen X; Luo Z
Sci Rep; 2016 Jun; 6():28139. PubMed ID: 27338725
[TBL] [Abstract][Full Text] [Related]
27. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.
Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z
Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823
[TBL] [Abstract][Full Text] [Related]
28. Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells.
Zhu X; Wang K; Zhang K; Zhu L; Zhou F
Toxicol Lett; 2014 May; 227(1):65-73. PubMed ID: 24680927
[TBL] [Abstract][Full Text] [Related]
29. Ursolic acid a promising candidate in the therapeutics of breast cancer: Current status and future implications.
Iqbal J; Abbasi BA; Ahmad R; Mahmood T; Kanwal S; Ali B; Khalil AT; Shah SA; Alam MM; Badshah H
Biomed Pharmacother; 2018 Dec; 108():752-756. PubMed ID: 30248543
[TBL] [Abstract][Full Text] [Related]
30. Quercetin inhibits proliferation and invasion acts by up-regulating miR-146a in human breast cancer cells.
Tao SF; He HF; Chen Q
Mol Cell Biochem; 2015 Apr; 402(1-2):93-100. PubMed ID: 25596948
[TBL] [Abstract][Full Text] [Related]
31. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
[TBL] [Abstract][Full Text] [Related]
33. Hyperoside induces apoptosis and inhibits growth in pancreatic cancer via Bcl-2 family and NF-κB signaling pathway both in vitro and in vivo.
Li Y; Wang Y; Li L; Kong R; Pan S; Ji L; Liu H; Chen H; Sun B
Tumour Biol; 2016 Jun; 37(6):7345-55. PubMed ID: 26676634
[TBL] [Abstract][Full Text] [Related]
34. Rabdosia rubescens inhibits breast cancer growth and angiogenesis.
Sartippour MR; Seeram NP; Heber D; Hardy M; Norris A; Lu Q; Zhang L; Lu M; Rao JY; Brooks MN
Int J Oncol; 2005 Jan; 26(1):121-7. PubMed ID: 15586232
[TBL] [Abstract][Full Text] [Related]
35. Sequential Therapy of Breast Cancer Cell Lines with Vitamin C and Quercetin Improves the Efficacy of Chemotherapeutic Drugs.
Ramezani F; Samadi N; Mostafavi-Pour Z
Nutr Cancer; 2017; 69(6):881-891. PubMed ID: 28742385
[TBL] [Abstract][Full Text] [Related]
36. Root extract of Prunella vulgaris inhibits in vitro and in vivo carcinogenesis in MCF-5 human breast carcinoma via suppression of angiogenesis, induction of apoptosis, cell cycle arrest and modulation of PI3K/AKT signalling pathway.
Gao W; Xu HLYLYLY
J BUON; 2019; 24(2):549-554. PubMed ID: 31128004
[TBL] [Abstract][Full Text] [Related]
37. Effects of Quercetin-Loaded Nanoparticles on MCF-7 Human Breast Cancer Cells.
Niazvand F; Orazizadeh M; Khorsandi L; Abbaspour M; Mansouri E; Khodadadi A
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 31013662
[No Abstract] [Full Text] [Related]
38. MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1.
Xie Q; Wang S; Zhao Y; Zhang Z; Qin C; Yang X
Oncotarget; 2017 Mar; 8(13):22003-22013. PubMed ID: 28423543
[TBL] [Abstract][Full Text] [Related]
39. Quinacrine and curcumin synergistically increased the breast cancer stem cells death by inhibiting ABCG2 and modulating DNA damage repair pathway.
Nayak D; Tripathi N; Kathuria D; Siddharth S; Nayak A; Bharatam PV; Kundu C
Int J Biochem Cell Biol; 2020 Feb; 119():105682. PubMed ID: 31877386
[TBL] [Abstract][Full Text] [Related]
40. MMGZ01, an anti-DLL4 monoclonal antibody, promotes nonfunctional vessels and inhibits breast tumor growth.
Xu Z; Wang Z; Jia X; Wang L; Chen Z; Wang S; Wang M; Zhang J; Wu M
Cancer Lett; 2016 Mar; 372(1):118-27. PubMed ID: 26739060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]